Review outlines effective approaches to reduce recurrent hepatic encephalopathy
Hepatic encephalopathy (HE) is a neurologic complication of advanced liver disease, causing impaired functioning, reduced quality of life…
U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need
Approval expands HYMPAVZI use to now include people with hemophilia A or B ages 12 years and older…
WHO prioritizes candidate vaccines and therapeutics for Bundibugyo virus
In response to the current outbreak of Ebola disease caused by Bundibugyo virus occurring in the Democratic Republic…
Young donor age proves critical for survival after stem cell transplantation
The selection of suitable donors is crucial for the long-term recovery of patients after an allogeneic hematopoietic stem…
Effectiveness and safety of thymopentin for infection prophylaxis in peritoneal dialysis patients: a retrospective study | BMC Nephrology
Millson T, Hackbarth D, Bernard HL. A demonstration project on the impact of safety culture on infection control…